IE38194L - 7-amino-7-alkoxycephalosporins - Google Patents
7-amino-7-alkoxycephalosporinsInfo
- Publication number
- IE38194L IE38194L IE731559A IE155973A IE38194L IE 38194 L IE38194 L IE 38194L IE 731559 A IE731559 A IE 731559A IE 155973 A IE155973 A IE 155973A IE 38194 L IE38194 L IE 38194L
- Authority
- IE
- Ireland
- Prior art keywords
- alkyl
- formula
- halogen
- phenyl
- alkanoyl
- Prior art date
Links
- -1 acetoxy, carbamoyloxy Chemical group 0.000 abstract 17
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 238000011065 in-situ storage Methods 0.000 abstract 2
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 abstract 1
- 125000001894 2,4,6-trinitrophenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O 0.000 abstract 1
- 101100188552 Arabidopsis thaliana OCT3 gene Proteins 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 125000005179 haloacetyl group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 abstract 1
- 125000006502 nitrobenzyl group Chemical group 0.000 abstract 1
- 125000006501 nitrophenyl group Chemical group 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 abstract 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 abstract 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1445743 Production of 7-amino and 7- acylamino-7-alkoxy cephalosporins ELI LILLY & CO 3 Oct 1973 [16 Oct 1972] 46093/73 Heading C2C Compounds of the formula wherein R‹ represents a primary C 1-4 alkyl group or -CD 3 ; R<SP>1</SP> represents an acetoxy, carbamoyloxy, α - methoxy - p - hydroxycinnamoyloxy, propionyloxy, benzoyloxy, methoxy, methylthio, 1 - methyl - 1,2,3,4- tetrazol - 5 - ylthio, or 5 - methyl - 1,3,4- thiadiazol - 2 - ylthio radical; R<SP>2A</SP> represents hydrogen or R<SP>2</SP>; and R<SP>2</SP> represents C 1-6 alkyl, 2,2,2 - trichloroethyl, 2 - iodoethyl, tert - C 5-7 - alkenyl, tert - C 5-7 - alkynyl, benzyl, nitrobenzyl, tetrahydropyranyl, succinimidomethyl, phthalimidomethyl, methoxybenzyl, dimethoxybenzyl, cyanomethyl, nitrophenyl, dinitrophenyl, 2,4,6 - trinitrophenyl, bis-(pmethoxyphenyl)methyl, triphenylmethyl, diphenylmethyl, benzyloxymethyl, C 3-6 - alkanoyloxymethyl, or phenacyl, are obtained by reacting an imino halide of the formula wherein X represents chlorine or bromine, R<SP>2B</SP> is the same as R<SP>2</SP>, C 2-4 -alkanoyl or a radical of the formula wherein each R<SP>3</SP> independently represents C 1-4 alkyl or halogen, provided that at least one R<SP>3</SP> represents C 1-4 alkyl; and R<SP>4</SP> represents an acylamino group wherein the acyl group is C 1-4 alkanoyl, benzoyl, naphthoyl, C 2-5 -alkoxycarbonyl, C 6-7 - cycloalkoxy - carbonyl, phenoxycarbonyl, benzyloxycarbonyl, naphthyloxycarbonyl, one of the said groups substituted with from one to three groups selected from halogen, nitro, C 1-4 -alkoxy, cyano, and in the case of benzoyl, naphthoyl, benzyloxy, and naphthyloxy, by C 1-4 -alkyl, or phthaloyl, with an alcohol of the formula under essentially non-aqueous conditions. Those compounds wherein R‹ represents-CD 3 are claimed to be novel. The products may subsequently be reacted, optionally in situ, with a compound of one of the formulae or wherein X represents halogen and R<SP>5</SP> represents C 1-8 alkanoyl, azidoacetyl, cyanoacetyl, haloacetyl, Ar-CH 2 -CO- where Ar denotes phenyl, thienyl, furyl, pyrrolyl, or phenyl substituted with from one to three substituents selected from halogen, trifluoromethyl, protected amino, protected hydroxy, C 1-3 alkyl, C 1-3 alkoxy, cyano and nitro, wherein Ar<SP>1</SP> represents phenyl, pyridyl, or substituted phenyl as defined above, and Y is oxygen or sulphur, Ar-CH(B)-CO- wherein Ar is as defined above and B is protected amino, protected hydroxy, protected carboxy,-CN or - N 3 , 2-(3-sydnone)acetyl or 2-(1H-tetrazol-1- yl)acetyl. The starting materials of Formula (II) are preferably prepared in situ by the reaction of a compound of the formula with PCl 5 or other acid halide. The products may be de-esterified where necessary and protecting groups may be removed by conventional means. The free acids of those products which have been reacylated possess antibacterial properties. Reference has been directed by the Comptroller to Specifications 1,348,984 and 1,348,987.
[GB1445743A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29816572A | 1972-10-16 | 1972-10-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE38194L true IE38194L (en) | 1974-04-16 |
| IE38194B1 IE38194B1 (en) | 1978-01-18 |
Family
ID=23149341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1559/73A IE38194B1 (en) | 1972-10-16 | 1973-09-03 | Process for producing 7-animo and 7-acylamino-7-alkoxycephalosporins |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS5541238B2 (en) |
| AR (1) | AR206204A1 (en) |
| AT (1) | AT328080B (en) |
| BE (1) | BE806068A (en) |
| BG (1) | BG25802A3 (en) |
| CA (1) | CA1042421A (en) |
| CH (1) | CH599221A5 (en) |
| CS (1) | CS188905B2 (en) |
| DD (1) | DD111210A5 (en) |
| DE (1) | DE2351375C2 (en) |
| DK (1) | DK153153C (en) |
| ES (1) | ES419313A1 (en) |
| FR (1) | FR2202895B1 (en) |
| GB (1) | GB1445743A (en) |
| HU (1) | HU166991B (en) |
| IE (1) | IE38194B1 (en) |
| IL (1) | IL43170A (en) |
| NL (1) | NL7314260A (en) |
| PL (1) | PL91578B1 (en) |
| RO (1) | RO63007A (en) |
| SE (1) | SE408424B (en) |
| SU (1) | SU686621A3 (en) |
| YU (1) | YU36972B (en) |
| ZA (1) | ZA736077B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5811955B2 (en) * | 1977-08-08 | 1983-03-05 | 山之内製薬株式会社 | Novel synthesis method for 7a-methoxycephalosporanic acid derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1348985A (en) * | 1970-06-16 | 1974-03-27 | Merck & Co Inc | Esters of cephalosporin compounds |
| DE2161659A1 (en) * | 1970-12-14 | 1972-08-03 | Yamanouchi Pharmaceutical Co. Ltd., Tokio | Process for the production of semi-synthetic penicillins |
-
1973
- 1973-01-01 AR AR250560A patent/AR206204A1/en active
- 1973-08-30 CA CA180,012A patent/CA1042421A/en not_active Expired
- 1973-09-03 IE IE1559/73A patent/IE38194B1/en unknown
- 1973-09-04 ZA ZA00736077A patent/ZA736077B/en unknown
- 1973-09-06 IL IL43170A patent/IL43170A/en unknown
- 1973-10-03 GB GB4609373A patent/GB1445743A/en not_active Expired
- 1973-10-03 ES ES419313A patent/ES419313A1/en not_active Expired
- 1973-10-08 RO RO7300076274A patent/RO63007A/en unknown
- 1973-10-10 YU YU2654/73A patent/YU36972B/en unknown
- 1973-10-12 SE SE7313930A patent/SE408424B/en unknown
- 1973-10-12 DE DE2351375A patent/DE2351375C2/en not_active Expired
- 1973-10-13 PL PL1973165827A patent/PL91578B1/pl unknown
- 1973-10-15 BE BE1005431A patent/BE806068A/en not_active IP Right Cessation
- 1973-10-15 FR FR7336757A patent/FR2202895B1/fr not_active Expired
- 1973-10-15 DD DD174064A patent/DD111210A5/xx unknown
- 1973-10-15 DK DK557473A patent/DK153153C/en not_active IP Right Cessation
- 1973-10-15 SU SU731964431A patent/SU686621A3/en active
- 1973-10-15 AT AT876073A patent/AT328080B/en active
- 1973-10-16 JP JP11674873A patent/JPS5541238B2/ja not_active Expired
- 1973-10-16 CH CH1465173A patent/CH599221A5/xx not_active IP Right Cessation
- 1973-10-16 NL NL7314260A patent/NL7314260A/xx active Search and Examination
- 1973-10-16 BG BG024765A patent/BG25802A3/en unknown
- 1973-10-16 CS CS737127A patent/CS188905B2/en unknown
- 1973-10-16 HU HUEI500A patent/HU166991B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE2351375A1 (en) | 1974-04-25 |
| AU6002873A (en) | 1975-03-06 |
| BG25802A3 (en) | 1978-12-12 |
| JPS4972289A (en) | 1974-07-12 |
| ES419313A1 (en) | 1976-06-16 |
| NL7314260A (en) | 1974-04-18 |
| IE38194B1 (en) | 1978-01-18 |
| FR2202895B1 (en) | 1978-11-10 |
| FR2202895A1 (en) | 1974-05-10 |
| YU265473A (en) | 1982-06-18 |
| SU686621A3 (en) | 1979-09-15 |
| CH599221A5 (en) | 1978-05-12 |
| AR206204A1 (en) | 1976-07-07 |
| BE806068A (en) | 1974-04-16 |
| RO63007A (en) | 1978-06-15 |
| JPS5541238B2 (en) | 1980-10-22 |
| PL91578B1 (en) | 1977-03-31 |
| DE2351375C2 (en) | 1985-07-11 |
| ATA876073A (en) | 1975-05-15 |
| DK153153B (en) | 1988-06-20 |
| HU166991B (en) | 1975-07-28 |
| YU36972B (en) | 1984-08-31 |
| ZA736077B (en) | 1975-04-30 |
| AT328080B (en) | 1976-03-10 |
| SE408424B (en) | 1979-06-11 |
| DD111210A5 (en) | 1975-02-05 |
| IL43170A (en) | 1976-08-31 |
| GB1445743A (en) | 1976-08-11 |
| IL43170A0 (en) | 1973-11-28 |
| CA1042421A (en) | 1978-11-14 |
| DK153153C (en) | 1988-12-05 |
| CS188905B2 (en) | 1979-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4071527A (en) | Certain benzothiazole compounds | |
| FI69847C (en) | NYTT FOERFARANDE FOER FRAMSTAELLNING AV 7- (SUBSTITUERAD) AMINO-3-SUBSTITUERAD-TIOMETYL- 3-CEFEM-KARBOXYLSYROR | |
| GB1401059A (en) | Derivatives of cephalosporins and penicillins | |
| GB948076A (en) | Cephalosporin compounds | |
| FI74967C (en) | NYTT FOERFARANDE FOER FRAMSTAELLNING AV 7- AMINO-3-SUBSTITUERAD-TIOMETYL- 3-CEFEM-4-CARBOXYLSYROR. | |
| GB1505885A (en) | Substituted cephalosporins | |
| IE38194L (en) | 7-amino-7-alkoxycephalosporins | |
| GB1421080A (en) | Process for the preparation of 7-acyl-amino-desacetoxy cephaolsporani acid esters | |
| GB1425571A (en) | Penicillins and cephaosporins | |
| GB1501711A (en) | Hydroxy-substituted cephalosporins | |
| GB1412856A (en) | Process for preparing desacetoxycephalosporins and intermediates | |
| GB1497039A (en) | Penicillins and cephalosporins | |
| GB1381272A (en) | Cephalosporin compounds | |
| ES423532A1 (en) | 3-halo cephalosporins | |
| GB1432925A (en) | 7-alpha-cyanomethylaryl-acetamide-cephalosporins | |
| US4242509A (en) | Process for producing 7-amino-7-alkoxycephalosporins | |
| US4203896A (en) | Acetoxy azetidin-2-one antibiotics via thiazolidine ring cleavage | |
| US4267340A (en) | Disulfide substituted oxazetidine derivatives | |
| GB1457668A (en) | Cephalo | |
| GB1421280A (en) | 3-heterocyclicthiomethylcephalosporins | |
| GB1211694A (en) | Derivatives of 7-aminocephalosporanic acid | |
| US3994939A (en) | Process for production of 6-amino-2,2-dimethyl-3-(5-tetrazolyl)penam and certain derivatives thereof | |
| IE36960B1 (en) | Cephalosporin intermediates and a process for the preparation thereof | |
| GB1130370A (en) | Esters of 6-aminopenicillanic acid | |
| US3957985A (en) | Mandelamidocephalosporins with improved properties |